concept

DEMYELINATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DEMYELINATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

338Connections

1Hypotheses

5Analyses

50Outgoing

50Incoming

0Experiments

5Debates

Summary

DEMYELINATION is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, causes. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 73 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DEMYELINATION
Key Genes/Proteins	ABCA1, AQP4
Related Diseases	aging, ALS, ALZHEIMER, Alzheimer'S Disease, ALZHEIMER'S DISEASE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Demyelination

mechanism · 3212 words

→

Pathway Diagram

graph TD
    DEMYELINATION["DEMYELINATION"]
    DEMYELINATION -->|"expressed in"| NEURON["NEURON"]
    DEMYELINATION -->|"expressed in"| NEURONS["NEURONS"]
    DEMYELINATION -->|"expressed in"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
    DEMYELINATION -->|"expressed in"| OLIGODENDROCYTES["OLIGODENDROCYTES"]
    DEMYELINATION -->|"activates"| MICROGLIA["MICROGLIA"]
    DEMYELINATION -->|"causes"| MYELINATION["MYELINATION"]
    DEMYELINATION -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
    DEMYELINATION -->|"causes"| INFLAMMATION["INFLAMMATION"]
    DEMYELINATION -->|"causes"| MULTIPLE_SCLEROSIS["MULTIPLE SCLEROSIS"]
    MS["MS"] -->|"causes"| DEMYELINATION
    Multiple_Sclerosis["Multiple Sclerosis"] -->|"causes"| DEMYELINATION
    AQP4_Antibody_Positive_NMOSD["AQP4-Antibody-Positive NMOSD"] -->|"involved_in"| DEMYELINATION
    MOGAD["MOGAD"] -->|"involved_in"| DEMYELINATION
    Classical_Complement_Cascade["Classical Complement Cascade"] -->|"causes"| DEMYELINATION
    Astrocyte_Injury["Astrocyte Injury"] -->|"contributes to"| DEMYELINATION
    BMPR1A["BMPR1A"] -->|"causes"| DEMYELINATION
    GPX4["GPX4"] -->|"causes"| DEMYELINATION
    ASK1["ASK1"] -->|"involved_in"| DEMYELINATION
    C9ORF72DIPEPTIDEREPEATPROTEINS["C9ORF72DIPEPTIDEREPEATPROTEINS"] -->|"causes"| DEMYELINATION
    INFLAMMATION -->|"causes"| DEMYELINATION

Outgoing (130)

Target	Relation	Type	Str
MULTIPLE SCLEROSIS	involved_in	entity	0.95
NEUROMYELITIS OPTICA SPECTRUM DISORDER	involved_in	entity	0.95
MOGAD	involved_in	entity	0.95
Reduced Signal Conduction	causes	phenotype	0.90
Multiple Sclerosis	biomarker_for	disease	0.90
Neuronal Loss	contributes_to	process	0.85
Postoperative neurocognitive disorder	contributes_to	disease	0.80
NEURON	activates	cell_type	0.80
REMYELINATION	exacerbates	phenotype	0.70
neurodegeneration	associated_with	disease	0.70
MITOCHONDRIAL DYSFUNCTION	exacerbates	phenotype	0.65
NEURODEGENERATION	triggers	process	0.65
NEUROINFLAMMATION	interacts_with	phenotype	0.65
TREM2	causes	gene	0.65
NEURONS	inhibits	cell_type	0.65
CYTOKINES	targets	phenotype	0.65
NEURON	associated_with	cell_type	0.65
OLIGODENDROCYTES	activates	cell_type	0.65
MBP	regulates	gene	0.65
ISCHEMIA	regulates	disease	0.65
NEURODEGENERATION	protects_against	disease	0.65
NEURODEGENERATION	destabilizes	phenotype	0.60
AXL	depleted_in	gene	0.55
ER STRESS	co_discussed	entity	0.50
SLEEP	co_discussed	entity	0.50
INFLAMMASOME	co_discussed	entity	0.50
MITOCHONDRIAL DYSFUNCTION	co_discussed	entity	0.50
TAU	co_discussed	entity	0.50
NLRP3	co_discussed	entity	0.50
GLIOSIS	activates	concept	0.50
MICROGLIAL ACTIVATION	activates	concept	0.50
NEURONS	co_discussed	cell_type	0.50
REMYELINATION	co_discussed	entity	0.50
STING	co_discussed	entity	0.50
NEURODEGENERATION	causes	entity	0.50
LIPID METABOLISM	co_discussed	entity	0.50
TLR4	co_discussed	entity	0.50
MICROGLIA	co_discussed	entity	0.50
NEURODEGENERATION	co_discussed	entity	0.50
MITOCHONDRIA	co_discussed	entity	0.50
MS	co_discussed	entity	0.50
REMYELINATION	activates	process	0.50
WHITE MATTER	activates	brain_region	0.50
RETINA	associated_with	brain_region	0.50
MACROPHAGE	co_discussed	entity	0.50
MACROPHAGES	co_discussed	entity	0.50
GLYMPHATIC	co_discussed	entity	0.50
FERROPTOSIS	co_discussed	entity	0.50
MLKL	co_discussed	entity	0.50
GFAP	co_discussed	entity	0.50

Incoming (208)

Source	Relation	Type	Str
MS	causes	disease	1.00
Progressive Multiple Sclerosis	associated_with	disease	0.95
Multiple Sclerosis	associated_with	disease	0.95
COMPLEMENT C3	contributes_to	protein	0.90
MOG-Associated Disease	associated_with	disease	0.90
35676653	can play a significant role in the MSc pathogenesis that results in	paper	0.90
MOG	implicated_in	protein	0.90
Immune-Glia Interactions	mediates	mechanism	0.90
AQP4	implicated_in	protein	0.90
Multiple Sclerosis	causes	disease	0.90
Oligodendrocyte Lineage Cells	contributes_to	cell_type	0.85
Astrocytic Mitochondrial Dysfunction	causes	mechanism	0.85
Central Nervous System Inflammation	causes	process	0.85
complement cascade	mediates	pathway	0.85
AQP4-Antibody-Positive NMOSD	involved_in	disease	0.85
Inflammatory Infiltrates	causes	cell_type	0.85
Classical Complement Cascade	causes	pathway	0.85
MOGAD	involved_in	disease	0.85
Soluble Factors	associated_with	compound	0.85
Microglia	contributes_to	cell_type	0.85
AQP4-Positive NMOSD	involved_in	disease	0.85
Astrocyte Injury	contributes_to	process	0.85
Astrocytes	contributes_to	cell_type	0.85
oligodendrocytes	implicated_in	cell_type	0.80
ASK1	involved_in	protein	0.80
Oxidative Injury	contributes_to	process	0.80
BMPR1A	causes	gene	0.80
SPG7	associated_with	gene	0.80
ASTROCYTE	causes	cell_type	0.80
PLA2G6	associated_with	gene	0.80
ASK1	contributes_to	gene	0.80
GPX4	causes	gene	0.80
Oligodendrocyte Lineage Cells	mediates	cell_type	0.80
ERLIN1	associated_with	gene	0.80
Astrocytes	mediates	cell_type	0.80
KCNQ2PROTEIN	associated_with	protein	0.80
Microglia	mediates	cell_type	0.75
C9ORF72DIPEPTIDEREPEATPROTEINS	causes	protein	0.70
EIF2AK3	causes	gene	0.70
ER stress	causes	pathway	0.70
CTNNA2	associated_with	gene	0.70
PRKAA1	associated_with	gene	0.70
XBP1	protective_against	protein	0.70
OLIGODENDROCYTES	destabilizes	cell_type	0.70
OPC maturation arrest	causes	phenotype	0.70
macrophage	causes	cell_type	0.70
OLIGODENDROCYTE	treats	cell_type	0.70
OLIGODENDROCYTE	stabilizes	cell_type	0.70
TH	inhibits	gene	0.70
AQP4 loss	causes	process	0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
MOG-IgG induces spinal cord demyelination through Fcγ recept	0.560	neuroinflammation	What are the specific pathophysiological

Mentioning Analyses (5)

Scientific analyses that reference this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

Related Research

Hypotheses and analyses mentioning DEMYELINATION in their description or question text

No additional research found

DEMYELINATION

Understanding Entity Pages

Summary

Wiki Pages (1)

Demyelination

Pathway Diagram

Outgoing (130)

Incoming (208)

Targeting Hypotheses (1)

Mentioning Analyses (5)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What specific gene expression signatures in aging mouse white matter predict hum

Why do clinical manifestations overlap despite distinct underlying etiologies in

What are the specific pathophysiological mechanisms underlying uncommon immune-m

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

Experiments (0)

Related Papers (0)

Debates (5)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and

The abstract mentions that antibody discovery has improved understanding of myel

The debate initiated investigation into white matter aging and myelin changes bu

The abstract notes that clinical presentations overlap across different myelopat

Related Research